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Abstract
The tear film is a thin fluid layer covering the ocular surface. It is responsible 
for ocular surface comfort, mechanical, environmental and immune protection, 
epithelial health and it forms smooth refractive surface for vision. The traditional 
description of the tear film divides it into three layers: lipid, aqueous and mucin. 
The role of each layer depends on the composition of it. Tear production, evapora-
tion, absorption and drainage concur to dynamic balance of the tear film and leads 
to its integrity and stability. Nonetheless, this stability can be disturb in tear film 
layers deficiencies, defective spreading of the tear film, in some general diseases 
and during application of some general and/or topical medications. Dry eye disease 
is the result of it. In this review not only physiology of the tear film is presented. 
Moreover, we would like to discuss the influence of various diseases and conditions 
on the tear film and contrarily, spotlight tear film disorders as a manifestation of 
those diseases.
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1. Introduction
The tear film is a thin fluid layer covering the ocular surface; it is the interface of 
the ocular surface with the environment. It is responsible for ocular surface comfort, 
mechanical, environmental and immune protection, epithelial (both corneal and 
conjunctival) health and it forms smooth, refracting surface for vision [1, 2]. Tear 
production (about 1,2 microliters per minute, total volume 6 microliters, 16% turn-
over per minute), evaporation, absorption and drainage are responsible for dynamic 
balance of the preocular tear film [1, 3–5]. Homeostatic balance leads to stability of 
the tear film, that makes possible to realize its functions as lubrication, nutrition 
and protection of ocular surface [3, 6]. Nonetheless, this stability can be disturb in 
tear film layers deficiencies, defective spreading of the tear film, in some general 
diseases and during application of some systemic and/or topical medications and 
dry eye disease evolves as a consequence of it. These review focused on physiology 
of the tear film, it’s meaning for the ocular surface stability and analyzed influence 
of various diseases and conditions on it.
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2. Tear film structure and function
The traditional description of the tear film is three-layered structure: super-
ficial-oily, middle - aqueous and mucous layer at the base [1–3]. A more recently 
proposed model consists of two layers: superficial – lipids and mucin/aqueous 
glycocalyx gel with decreasing mucin concentration from epithelium to lipid layer 
[1, 3, 7, 8]. Some authors says, that the tear film is a single unit that acts like a fluid 
shell [9] (Table 1 and Figure 1).
2.1 Lipids
The lipid layer is secreted by Meibomian glands, located within tarsal plates of 
upper and lower eyelids with some small contribution by Moll (modified apocrinic, 
sudoriferous) and Zeiss (modified subeceous) glands, located within superior 
and lower eyelids (connected with hair follicles) and possibly epithelial cells. The 
posterior, aqueous interface consists of polar lipids: ceramides, cerebrosides and 
phospholipids. The lipid-air interface is formed with nonpolar lipids: cholesterol 
esters, triglycerides and free fatty acids [1, 3, 7, 8, 10].
The main function of the lipid layer is to reduce evaporation of tears and 
improve the stability of them. Moreover, the lipid layer provides smooth refracting 
surface, limits contamination of ocular surface from particles (dust) and microor-
ganisms, prevents tear contamination by skin lipids, limits aqueous layer surface 
tension and counteracts tears overflowing onto the skin. [1, 3, 7–14].
Regulation of lipid secretion supervenes through modulation of lipid synthesis or 
cell maturation. The Meibomian gland secretion is a subject of neuronal, hormonal 
Tear film layer Function
Lipid layer 
(meibum)
• Form the outer layer of the tear film.
• Minimize the evaporation of water from the eye surface
• Isolate ocular surface from the environment
• Improve the stability of tear film
• Provide smooth refracting surface
• Limit contamination of ocular surface from particles(dust) and microorganisms
• Prevent tear contamination by skin lipids
• Limit aqueous layer surface tension
• Counteract tears overflowing onto the skin
Aqueous phase • Constitutes roughly 90% of the tear film volume
• Lubricate the ocular surface
• Wash away foreign bodies and contaminations
• Nourish the avascular cornea (oxygen, proteins, inorganic salts)
• Include proteins (lysozyme, lactoferrin, lipocain), immunoglobulins, defensins and 
glycoproteins responsible for anti-microbial activity
• Include growth factors, vitamins and electrolytes necessary for ocular surface health 
and epithelial integrity
• Realign corneal microirregularities (refractive properties)
Mucous layer • Form a glycocalyx over the ocular epithelium that prevents pathogen adhesion
• Bind water to hydrate and lubricate the ocular surface.
• Reduce friction during blinking
• Clear the surface of pathogens and debris
• Contribute to tear stability
• Take part in regulation of epithelial growth
• Might be involved in cellular signaling
Table 1. 
The function of tear film layers.
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and vascular influences. Androgen, estrogen and progesterone receptors have been 
identified in adult male and female rats, rabbits and humans. It is suggested that 
androgens stimulate and estrogens reduce Meibomian secretion [14–17]. Moreover, 
Meibomian gland function may be under direct neuronal (predominant parasympa-
thetic, also sympathetic and sensory sources) or indirect vascular (vasoactive intesti-
nal polypeptide VIP) influence to control lipid synthesis and/or excretion [2, 14, 15].
2.2 Aqueous component
The main non-reflex production of aqueous part of mucin/aqueous gel is from 
the Krauze and Wolfring glands (accessory lacrimal glands) located in the conjunc-
tiva of superior eye lid and superior conjunctival fornix. The main lacrimal gland is 
responsible for aqueous tears production secondary to deleterious stimulation and 
plays important, though not entirely clear role in non-reflecting tearing (dry eye 
syndrome is noted in patients with damaged main lacrimal gland) [1, 7, 8, 11, 18]. 
The aqueous layer consists of water, electrolytes, proteins, cytokines, vitamins, 
immunoglobulins and peptide growth factors. Moreover, amino acids, bicarbonate, 
calcium, urea and magnesium were detected in tear film [15, 19].
The aqueous portion of the tear film is responsible for ocular surface lubrication, 
washing away foreign bodies or contaminations and nourishing avascular cornea 
(oxygen, inorganic salts, proteins, glucose) [3, 16, 20]. The soluble mucins decrease 
the surface tension, impact coherence of the aqueous layer, contribute to tear film 
Figure 1. 
Structure of the tear film: 1. Three layer conception. 2. Two layer conception.
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viscosity [14, 19]. Almost 500 different proteins have been extracted from the tear 
film [3, 21]. Lactoferrin, lysozyme, lipocalin, secretory immunoglobulin A(sIgA), 
immunoglobulin G(IgG), immunoglobulin M (IgM), albumin, transferrin, ceru-
loplasmin, defensins, tear specific prealbumin and glycoproteins participate in 
the ocular surface antimicrobial activity and defense [3, 15, 22]. Growth factors, 
vitamins, electrolytes, neuropeptides and protease inhibitors are necessary for 
retaining ocular surface health and epithelial integrity [1, 3, 23]. Retinol, secreted 
by the lacrimal gland, is necessary for maintenance of goblet cells and regulates 
corneal epithelium desquamation, keratinization and metaplasia [15, 24–26].
The lacrimal gland is affected by both nervous system and various hormones 
[1, 2, 7, 11, 15, 18, 23, 27]. The gland innervation comes from the first brunch of 
trigeminal nerve, the facial nerve and sympathetic fibers from the superior cervical 
ganglion [1, 11, 15, 28]. Stimulation of the ocular surface is the beginning of the 
main lacrimal gland production (reflexing tearing). The emotional tearing is also 
connected with this reflex loop (Figure 2). The meaning of the sympathetic part of 
innervation is thought to stimulate basal tearing but is still not completely under-
stood. The accessory lacrimal glands are heavily innervated, but there is lack of 
parasympathetic part and most of the innervation is undefined [8, 15, 29].
Androgens and estrogens influence lacrimal gland production. Androgens lack is 
responsible for reversible degenerative changes of lacrimal gland, decreased volume 
of the tears, decreased level of proteins in tears. Estrogens remain controversial: 
some studies described estrogen deficiency linked to keratoconjunctivitis sicca 
(KCS) and lacrimal gland degeneration, other works have shown no changes in the 
lacrimal gland and tear film with decreased level of estrogens [15, 17, 30, 31]. Thyroid 
stimulating hormone (TSH) receptors (present in lacrimal gland) as well as thyroid 
Figure 2. 
Reflex loop of tearing: 1. Stimulants: - ocular surface and nasal mucosa - afferent arm of the loop (first branch 
of the fifth cranial nerve)- emotions, 2. brain - efferent arm of the loop (parasympathetic part of the seventh 
nerve), 3. lacrimal glands.
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hormone and tissue interaction are necessary for lacrimal gland secretion. Adequate 
insulin level is important for lacrimal gland and ocular surface stability and function, 
because it is necessary for acinar cell and cornea epithelial cell proliferation [32].
2.3 Mucins
The mucous layer of the tear film is produced by both corneal and conjunctival 
epithelium and the lacrimal gland and conjunctival goblet cells [1, 3, 7, 11, 15, 33]. It 
is composed of secreted and transmembrane mucins, immunoglobulins, salts, urea, 
glucose, leukocytes, cellular debris and enzymes [1, 3, 15, 33–35].
Traditional description of the mucins role limits to secreted gel-forming mucins 
working as lubricating agents and clearing molecules. Current date indicate its role 
also as a barrier for corneal and conjunctival epithelium. We can find two kinds of 
the mucins: cell surface-associated and secreted [36].
Cell surface-associated mucins form a thick cell surface glycocalyx, providing 
through their O-glucans a disadhesive character to the apical surface of the corneal 
epithelium. That is why they assure boundary lubrication and prevent adhesion of 
corneal epithelium and tarsal conjunctiva during blinking and sleeping [36, 37]. 
Moreover, membrane-bound mucins take part in the maintenance of the mucosal 
barrier integrity to prevent the penetrance molecules onto ocular surface epithe-
lia [36, 38]. Some recent studies have weighed up membrane-bound mucins as 
 osmosensors in eukaryotic cells [36, 39, 40].
Secreted mucins have a capability to trap contaminations (e.g. allergens, debris, 
pathogens) in order to clearance them from mucosal surface. Gel-forming mucins 
retaining water, form highly hydrated gel to lubricate ocular surface and reduce 
shear stress during blinking or rubbing. Moreover, MUC 7 (detected in lacrimal 
gland), has potent antifungal and antimicrobial activity [34, 35, 37, 41–43].
Goblet cells may be stimulated for mucin secretion by histamine, antigen, immune 
complex, mechanical action (i.e. blinking), direct (muscarinic and α-adrenergic recep-
tors on immature goblet cells) and indirect (sensory, sympathetic and parasympathetic 
innervation of conjunctiva surrounding goblet cells) neural control [15, 16, 44–46].
2.4 Tear film dynamics
Balanced tear film production and elimination is crucial for its integrity, stability 
and right osmolality [3]. Tear film production is a complex process, controlled by 
the various factors: main and accessory lacrimal glands, ocular surface structures 
(cornea, conjunctiva, eyelids with Meibomian gland) and interconnecting nerves 
(both sensory and motor) [3, 47, 48]. Ryc.1. Tears elimination proceeds as evapora-
tion, drainage and absorption. Tear film interfaces with the environment; that is the 
reason of evaporation (about 1,4–39,3 x 10−7 g/cm2/s) [5, 49]. Some environmental 
factors like humidity, temperature and air movements impact the rate of tear evapo-
ration from the ocular surface [50]. Higher evaporation is the reason of tear film 
thinning and, because of that, instability and hyperosmolality [51]. Regardless of 
the recent date on evaporation, tears outflow through the lacrimal drainage system 
remains the main way of its elimination. With each blink, tears with contamina-
tions (like cellular debris, toxins, inflammatory cells and other waste products) are 
moved towards the lacrimal puncta and next - due to the negative pressure created 
in lacrimal drainage system - to the lacrimal drainage tract [3, 52]. Some studies 
noted reduction of tears production in patients with impaired drainage that high-
lights the importance of this process in the model of tear dynamics [53–55]. At least 
absorption: process necessary for proper tear film dynamics, connected with cornea, 
conjunctiva and - mainly - nasolacrimal duct epithelium [56]. The equilibrium in 
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the tear film production, retention and elimination acts the crucial role in its proper 
functioning, thereby ocular surface health [3].
3. The influence of various diseases and conditions on the tear film
Tear film stability can be disturb in tear film layers deficiencies, defective 
spreading of the tear film, in some general diseases and during application of 
some general and/or topical medications. In the wake of it dry eye disease evolves 
[11, 36, 57] (Tables 2 and 3).
3.1 Lipid layer alteration
Deficiency of this layer is the reason of more rapid evaporation and in the absence 
of increased tear production activates evaporative form of dry eye disease [58].
The most common reason of lipid layer deficiency is obstruction of the 
Meibomian glands. Meibomian gland disfunction (MGD) may be provoked by 
various local and systemic conditions, e.g. atopic keratoconjunctivitis, chronic 
blepharitis [59, 60], generalized dysfunction of sebaceous glands (rosacea, sebor-
rheic dermatitis), chemical agents such as turpentine, present in the sick building 
environment [36, 61]. Tobacco smokers are prone to development of MGD [62], 
the more severe course of MGD was observed in type 2 diabetes mellitus [63].
Dry eye
Aqueous deficient dry eye (ADDE) Evaporative dry eye (EDE)




Meibomian gland dysfunction (MGD)
Disorders of lids and lid aperture
Low blinking
Systemic medicines
Non- Sjőgren Syndrome dry eye
Lacrimal deficiency









Dry eye classification [7, 23, 64–74].
Dry eye disease
Signs Symptoms
• Discomfort: itching, stinging, 
burning, “foreign body sensation” 
occasionally pain, photophobia
• Visual fluctuations (especially during 
reading- blinking recover vision)
• Tear film instability (potential dam-
age of ocular surface)
• Eyelids: blepharitis posterior, Meibomian gland disfunc-
tion, trichiasis, symblepharon
• Conjunctiva: hyperemia, keratonization, persistent inflam-
mation, dyeing with the lissamine green(rose bengal)
• Tear film: debris, reduced meniscus, instability(reduced 
break-up time), elevated osmolarity and level of inflam-
matory mediators
• Cornea: epithelial defect (dyeing with the fluorescein), 
filaments, mucus clumping
• Potential complications: persistent epithelial defect, 
keratomalacia, corneal perforation, corneal ulcer
Table 3. 
Signs and symptoms of dry eye disease [1, 7, 23, 64].
7
Tear Film – Physiology and Disturbances in Various Diseases and Disorders
DOI: http://dx.doi.org/10.5772/intechopen.94142
Furthermore, the insufficient protein intake in bariatric patients negatively 
influences tear film lipids [75]. Also androgen deficiency (e.g. aging, anti-androgen 
therapy, congenital impairment or absence of the androgen receptor) hinders lipid 
production [76]. Incomplete blinking has been reported as the reason for lipid 
layer instability, because of inadequate lipid distribution [9, 77]. Some studies 
have revealed influence of medicines on the lipid layer: e.g. isotretinoin decreases 
Meibomian gland secretory ability [78], and on the contrary, botulinum neurotoxin 
A injections seem to increase lipid layer thickness [79].
3.2 Aqueous layer disturbances
Aqueous layer deficiency is the most common reason of dry eye and is classi-
fied into two groups: Sjögren Syndrome dry eye and non-Sjögren Syndrome dry 
eye [64, 65].
Sjögren’s syndrome (SS) is a rheumatic autoimmune disease in which exocrine 
glands (salivary and lacrimal glands) are involved that results in clinical symptoms 
of dry mouth and dry eye. SS can be primary-pSS (without any other accompany-
ing symptoms) or secondary-sSS (with other autoimmune diseases: systemic lupus 
erythematosus (SLE), rheumatoid arthritis (RA), polyarteritis nodosa, systemic 
sclerosis, granulomatosis with polyangiitis (GPA), primary biliary cholangitis (PBC), 
mixed connective tissue disease, occult thyroid eye disease) [64, 66]. Some studies 
demonstrated coincidence of dry eye disease (DED) and SS in 46.7% cases [64, 67].
In non-SS dry eye reduced tear secretion is a result of senile hyposecretion, 
lacrimal excision, lacrimal duct obstruction, immune lacrimal gland damage in 
sarcoidosis or lymphoma, sensory or motor reflex block, scarring conditions of the 
conjunctiva (pemphigoid, chemical burns, trachoma, chronic ocular Graft-versus-
Host Disease) [11, 57, 64, 68, 69]. Corneal hypoesthesia and due to it dry eye can 
be result of corneal refraction surgery [70], contact lens wearing [71], herpetic 
keratitis or as a side effect after surgical trigeminal neuralgia management [72].
Increased electrolyte concentration, loss of growth factors, presence of proin-
flammatory cytokines result in changes in composition of the aqueous part of the 
tear film. Such a disturbances in connection with slow tear turnover are secondary 
to ocular surface damage [8, 47].
There are some medicines reported to exacerbate tear secretion, e.g. thiazide 
diuretics, tricyclic and tetracyclic antidepressants, ß-blokers, anticholinergics, 
benzodiazepines, antihistamines, antihypertensives and anti-Parkinson’s drugs 
[8, 57, 73, 74].
3.3 Mucin layer deficiency
Disturbances of the mucin layer are connected with the goblet cell deficiency, 
which is observed in majority forms of dry eye [8, 80]. The leading reason of xeroph-
thalmia connected with mucins the insufficiency of vitamin A is [8, 57, 81, 82].  
The lack of vitamin A is usually connected with various forms of malnutrition or 
chronic malabsorption. Gastroenterological diseases (e.g. coeliac disease) impair 
vitamin A absorption [83–85]. Conditions affecting liver impair fat metabolism and 
decreases absorption of this fat-soluble vitamin [86, 87]. Pancreas insufficiency 
(e.g. cystic fibrosis) hinders vitamin A intake by its influence on fat digestion path-
way [88, 89]. Alcoholism, restrictive diets (both in eating disorders and selective, 
like poor balanced vegans’) and low-quality food consumption are the most com-
mon reasons of malnutrition and because of that vitamin A insufficiency [90–94].
There are some problems responsible for impairment of goblet cells function. 
Mucous membrane pemphigoid and its subtype – ocular cicatricial pemphigoid 
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via recurrent inflammation destroy goblet cells and promote subepithelial fibrosis, 
resulting in changes ranging from xerophthalmia to conjunctival keratinization 
and blindness [95–99]. Stevens-Johnson Syndrome, trachoma and severe burns 
(both thermal and chemical) impair mucin production by decreasing the number of 
active goblet cells [8, 100–103].
Moreover, some medications (e.g. mucolytics, antihistamines) and preservatives 
influence the ocular surface and modify mucous layer [8, 57, 104].
3.4 Multilayer disturbances
Although three layers of the tear film are investigated, all of them remain in strict 
dependence of each other and many conditions cause disturbances of the tear film 
as a whole. The most common problem impairing ocular surface is progression with 
age; decreased tear production, tantalic problems, hormonal changes, medications 
and other diseases affect tear production, its’ ingredients and spreading over the 
ocular surface [8, 57, 105, 106]. Tantalic dry eye seems to be one of the most impor-
tant conditions influencing all three layers: eyelid incongruency (entropion, ectro-
pion, lid margin irregularities, exophthalmos), epitheliopathy (e.g. corneal scars) 
and evaporation are the reason of tear loss. Neurological problems (both afferent 
and efferent part of the reflex loop) directly affect tear secretion [8, 57, 105].
Hormonal changes (androgens, estrogens, prolactin, thyroid hormone, insulin 
resistance/deprivation, ACTH resistance, adrenal insufficiency, multiple endocrine 
deficiency) influence tear stability as well [105, 106]. Meanwhile, the newest meta-
analysis revealed no correlation between hormonal replacement therapy or oral 
contraceptives and tear film – it seems to be speculative [107, 108]. Dry eye disease 
due to hormonal disorders often connect both aqueous tear deficient and evaporative 
mechanism. Thyroid associated diseases result usually in autoimmune condition 
(impaired thyroid hormone activity, autoantibodies against THS receptors present 
in lacrimal glands, autoantibodies against thyroid hormone and/or their receptors) 
but the final effect of dry eye is connected also with ocular surface disturbances 
due to enhanced environment exposure, lid mechanical impairment (reduced lipids 
secretion, eyelid retraction, eye globe proptosis, impaired blinking) and therapy 
(thyroid hormone replacement, iodine suppression, immunomodulators specific 
for orbit and ocular disease, local radiotherapy and surgical procedures) [106]. In 
patients with diabetes mellitus the frequency of dryness varies from 15.4 to 82%. 
The mechanism of dry eye disease in diabetic patients is multifactorial: insulin 
resistance or deprivation is responsible for lacrimal gland size reduction, histological 
and molecular changes of it, polyneuropathy and nerve-conduction abnormalities 
that reduce secretion. Peripheral microvascular disease and insulin reduced input 
in target tissues are the other reasons of lacrimal gland and ocular surface disorders. 
Tear film instability and higher osmolarity are probably the result of higher glucose 
and protein levels in the tears and changes in the protein profile [106, 109].
In literature there are examples of dry eye disease secondary to other hormonal 
imbalance (e.g. ACTH-triple A syndrome, multiple endocrine deficiency) [106, 110].
Some environmental factors (e.g. pollutions, visual display terminals, tempera-
ture, humidity) promotes dry eye disease, however the pathomechanism is still 
discussed [111, 112]. Contact lenses wear influences lipid layer, changes the dynamics 
of the whole tear film and is the reason of dry eye symptoms [113–115].
There are a lot of date on the influence of medications (both topical and systemic) 
on the tear film. Some samples: ß-blockers used for glaucoma therapy reduce test 
Shirmer I and break-up time values, long term general anesthesia decrease basal 
tear production, antihistamines block both goblet cells and lacrimal glands, topi-
cal glaucoma therapy reduces LLT, oral mucolytics modify mucous layer, systemic 
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antidepressants, anticholinergics or antihypertensives increase risk of dry eye 
problems [56, 103, 116–122]. A comprehensive review of this problem with the list of 
medicines and herbs has been prepared by Askeroglu et al. [123]. Analyzing influ-
ence of medicines on the ocular surface and dry eye disease we have to remember that 
topical used multidose artificial tears and lubricants contain preservatives. The most 
common Benzalkonium chloride – BAK disrupts tear stability, causes corneal and 
conjunctival epithelium damage and induces inflammatory changes that depends on 
dose and time of use. Alternative preservatives (e.g. Polyquaternium-I: Polyquad®, 
Polyhexamethylene biguanide: PHMB, Sodium perborate: GenAqua®, Deqest®, 
stabilized Oxychlorocomplex SOC: Purite®, OcuPure®, ionic-buffered solution 
containing zinc chloride, borate, propylate glucol and sorbitol:Sofzia) are used in 
some artificial tears, lubricants or glaucoma drops. Published date on the ocular 
performance of them generally show they induce significantly less disturbances of 
the ocular surface than BAK [124, 125] (Table 4).
4. Conclusions
The ocular surface contacts with the environment by the tear film as interface. 
Thus, tear production, composition, dynamics and function is so important to 
prevent it healthy. There are many diseases and conditions (both systemic and 
Causes of disturbances
Lipid layer MGD: atopic local changes, chronic blepharitis, generalized dysfunction of the sebaceous 
glands, chemical agents, tabacco smokers, diabetes mellitus
Insufficient protein intake (bariatric patients)
Androgen deficiency: aging, anti-androgen therapy, congenital impairment or absence of 
the androgen receptor
Incomplete blinking (inadequate lipid distribution)
Medicins
Aqueous layer • Sjőgren syndrome dry eye (SSDE)
(primary, without other accompanying symptoms and secondary, with other 
autoimmune diseases)
• Non- Sjőgren syndrome dry eye (nSSDE)
(senile hyposecretion, lacrimal excision, lacrimal duct obstruction, immune lacrimal 
gland damage, sensor or motor reflex block, scarring condition of the conjunctiva, 
corneal hypoesthesia as a result of CL wearing, heretical keratitis or surgical procedures)
• Medicines
Mucus layer • Insufficiency of vitamin A: malnutrition or malabsorption (gastroenterological 
diseases, condition affecting liver, pancreas insufficiency, alcoholism, restrictive 
diets, low quality food)
• Destruction of the goblet cells (cicatricial conjunctival changes: e.g. pemphigoid, 
Stevens-Johnson syndrome, trachoma, GVHD, severe thermal and chemical burns)
• Medicines
Multilayer • Aging: decreased tear production, tantalic problems (eyelid incongruency as 
entropion, ectropion, eyelid irregularities, exophthalmos, epitheliopathy; e.g. corneal 
scars)
• Hormonal changes (androgens, estrogens, prolactin, ACTH, thyroid hormone)
• Neurological problems (both afferent and efferent part of the reflex loop)
• Environment (pollutions, ambient temperature, humidity)
• Visual display terminals
• Medicines (both topical and systemic)
• Preservatives
Table 4. 
The main causes of tear film deficiency [7, 58–125].
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local) that may affect each layer of the tear film separately or all of them together. 
Moreover, tear film disorders can manifest systemic diseases and, sometimes, 
be necessary or even be the only clue to diagnosis. The commonness of tear film 
problems and wide spectrum of its different background seem to require to be con-
sidered in everyday medical, not only ophthalmological, practice. Those problems 
should be analyzed to plan and undertake proper therapy, especially in patients 
with eye dryness symptoms.
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